Top News: United States Steel Corp. (NYSE:X), Seattle Genetics Inc. (NASDAQ:SGEN), Naugatuck Valley Financial Corporation (NASDAQ:NVSL), National CineMedia (NASDAQ:NCMI), SK Telecom (NYSE:SKM)

On Oct 28, United States Steel Corp. (NYSE:X) posted a narrower loss, as revenue increased and the company said U.S. market conditions have remained stable. For the quarter ended Sept. 30, the company posted a loss of $207 million, or $1.42 a share, compared with a loss of $1.79 billion, or $12.38 a share, a year earlier, which reflected a $1.78 billion impairment charge. United … Continue reading Top News: United States Steel Corp. (NYSE:X), Seattle Genetics Inc. (NASDAQ:SGEN), Naugatuck Valley Financial Corporation (NASDAQ:NVSL), National CineMedia (NASDAQ:NCMI), SK Telecom (NYSE:SKM)

Kevin Long11/1411/14

Shining on Major News: MannKind Corp. (NASDAQ:MNKD), Exelon Corporation (NYSE:EXC), Coca-Cola Company (NYSE:KO), Seattle Genetics (NASDAQ:SGEN), Yum! Brands, Inc. (NYSE:YUM)

On August 11,2014 MannKind Corp. (NASDAQ:MNKD) reported financial results for the second quarter ended June 30, 2014. For the second quarter of 2014, total operating expenses were $69.8 million, compared to $41.6 million for the second quarter of 2013, an increase of $28.2 million, largely due to an increase in non-cash stock compensation expense of $30.5 million. MannKind Corp. (NASDAQ:MNKD) belongs to Healthcare sector. Its … Continue reading Shining on Major News: MannKind Corp. (NASDAQ:MNKD), Exelon Corporation (NYSE:EXC), Coca-Cola Company (NYSE:KO), Seattle Genetics (NASDAQ:SGEN), Yum! Brands, Inc. (NYSE:YUM)

Chris Lewis08/2208/22

Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -12.94%. Checkpoint Systems, Inc. (NYSE:CKP) … Continue reading Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

Mark Doerr08/0708/07

Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares of common stock in this offering. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) … Continue reading Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Adam Keintzel07/1007/10

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) major shareholder Qvt Associates Gp Llc sold 128,649 shares of the company’s stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $7.66, for a total transaction of $985,451.34. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -6.32% in last session and finished the day at $6.38. Traded volume was 21.04million shares in the last … Continue reading Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Mark DeFrance06/1306/13

Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

Seattle Genetics, Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) stock performance was -0.05% … Continue reading Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

John Bellich06/1306/13